Abbott Laboratories (ABT) Non-Current Deferred Tax Liability (2010 - 2021)
Abbott Laboratories (ABT) posted Non-Current Deferred Tax Liability of $1.4 billion for Q4 2021, down 1.0% sequentially from $1.4 billion in Q4 2020, and down 1.0% YoY from $1.4 billion in Q4 2020.
Abbott Laboratories (ABT) Non-Current Deferred Tax Liability (2010 - 2021) Analysis & Trends
Abbott Laboratories has reported Non-Current Deferred Tax Liability for 12 years, with the latest figure at $1.4 billion in Q4 2021.
- Quarterly Non-Current Deferred Tax Liability fell 1.0% year-over-year to $1.4 billion in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $1.4 billion (down 1.0% YoY) and the FY2021 annual result came in at $1.4 billion, down 1.0% from the prior year.
- Non-Current Deferred Tax Liability eased to $1.4 billion in Q4 2021 per ABT's latest filing, from $1.4 billion in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $2.1 billion in Q4 2018 and troughed at $1.4 billion in Q4 2021.
- A 5-year average of $1.7 billion and a median of $1.5 billion in 2019 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2017 and 2019: Non-Current Deferred Tax Liability jumped 463.48% in 2017, then slipped 24.81% in 2019.
- Over 5 years, Non-Current Deferred Tax Liability stood at $2.0 billion in 2017, then gained by 2.49% to $2.1 billion in 2018, then retreated by 24.81% to $1.5 billion in 2019, then dropped by 9.06% to $1.4 billion in 2020, then declined by 1.0% to $1.4 billion in 2021.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $1.4 billion, $1.4 billion, and $1.5 billion for Q4 2021, Q4 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.29 Bn | 18.88 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1.39 Bn |
| Dec 31, 2021 | 1.39 Bn |
| Dec 31, 2020 | 1.41 Bn |
| Dec 31, 2020 | 1.41 Bn |
| Dec 31, 2019 | 1.55 Bn |
| Dec 31, 2019 | 1.55 Bn |
| Dec 31, 2018 | 2.06 Bn |
| Dec 31, 2018 | 2.06 Bn |
| Dec 31, 2017 | 2.01 Bn |
| Dec 31, 2017 | 2.01 Bn |
| Dec 31, 2016 | 356.00 Mn |
| Dec 31, 2016 | 356.00 Mn |
| Dec 31, 2015 | 808.00 Mn |
| Dec 31, 2015 | 808.00 Mn |
| Dec 31, 2014 | 872.00 Mn |
| Dec 31, 2014 | 872.00 Mn |
| Dec 31, 2013 | 466.00 Mn |
| Dec 31, 2013 | 466.00 Mn |
| Dec 31, 2012 | 710.00 Mn |
| Dec 31, 2012 | 710.00 Mn |